Arsalan Shabbir

2.6k total citations · 1 hit paper
44 papers, 1.6k citations indexed

About

Arsalan Shabbir is a scholar working on Surgery, Dermatology and Rheumatology. According to data from OpenAlex, Arsalan Shabbir has authored 44 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 13 papers in Dermatology and 11 papers in Rheumatology. Recurrent topics in Arsalan Shabbir's work include Eosinophilic Esophagitis (14 papers), Dermatology and Skin Diseases (10 papers) and Mesenchymal stem cell research (8 papers). Arsalan Shabbir is often cited by papers focused on Eosinophilic Esophagitis (14 papers), Dermatology and Skin Diseases (10 papers) and Mesenchymal stem cell research (8 papers). Arsalan Shabbir collaborates with scholars based in United States, Netherlands and Japan. Arsalan Shabbir's co-authors include Evangelos V. Badiavas, Marcela Salgado, Luis Rodriguez-Menocal, Techung Lee, Audrey Cox, David Zisa, Gen Suzuki, Huey Lin, Christopher Cardozo and Avrom J. Caplan and has published in prestigious journals such as Gastroenterology, PLoS ONE and Gut.

In The Last Decade

Arsalan Shabbir

40 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mesenchymal Stem Cell Exosomes Induce Proliferation and Migration of Normal and Chronic Wound Fibroblasts, and Enhance Angiogenesis In Vitro

2015 550 citations Arsalan Shabbir, Audrey Cox et al. Stem Cells and Development profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arsalan Shabbir United States	17	738	599	491	289	233	44	1.6k
Loubna Mazini Morocco	13	538 0.7×	461 0.8×	255 0.5×	232 0.8×	194 0.8×	19	1.3k
Chu-Tse Wu China	25	826 1.1×	733 1.2×	491 1.0×	93 0.3×	175 0.8×	84	2.0k
Ivan N. Vial United States	11	388 0.5×	357 0.6×	363 0.7×	603 2.1×	205 0.9×	17	1.5k
Rica Tanaka Japan	19	521 0.7×	347 0.6×	354 0.7×	457 1.6×	125 0.5×	58	1.5k
TacGhee Yi South Korea	24	493 0.7×	737 1.2×	424 0.9×	87 0.3×	213 0.9×	44	1.5k
Richard J. Bauer Germany	22	727 1.0×	196 0.3×	220 0.4×	198 0.7×	199 0.9×	55	1.6k
Yin Hu China	10	1.0k 1.4×	219 0.4×	159 0.3×	236 0.8×	477 2.0×	12	1.5k
Kantima Leelahavanichkul United States	9	822 1.1×	1.4k 2.4×	630 1.3×	185 0.6×	247 1.1×	12	2.5k
Minjuan Wu China	18	1.6k 2.1×	349 0.6×	248 0.5×	223 0.8×	1.0k 4.5×	64	2.2k
Fangfei Nie China	12	428 0.6×	189 0.3×	173 0.4×	358 1.2×	138 0.6×	34	968

Countries citing papers authored by Arsalan Shabbir

Since Specialization

Citations

This map shows the geographic impact of Arsalan Shabbir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arsalan Shabbir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arsalan Shabbir more than expected).

Fields of papers citing papers by Arsalan Shabbir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arsalan Shabbir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arsalan Shabbir. The network helps show where Arsalan Shabbir may publish in the future.

Co-authorship network of co-authors of Arsalan Shabbir

This figure shows the co-authorship network connecting the top 25 collaborators of Arsalan Shabbir. A scholar is included among the top collaborators of Arsalan Shabbir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arsalan Shabbir. Arsalan Shabbir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Collins, Margaret H., Marc E. Rothenberg, Evan S. Dellon, et al.. (2025). Dupilumab Improves Histopathologic Features in Patients With Eosinophilic Esophagitis: LIBERTY EoE TREET Study Results. Gastro Hep Advances. 4(6). 100646–100646.

Beck, Lisa A., Robert Bissonnette, Mette Deleuran, et al.. (2024). Dupilumab in Adults With Moderate to Severe Atopic Dermatitis. JAMA Dermatology. 160(8). 805–805. 30 indexed citations

Bredenoord, Albert J., Evan S. Dellon, Ikuo Hirano, et al.. (2024). Sa1275 IMPROVEMENTS IN HISTOLOGIC, SYMPTOMATIC, AND ENDOSCOPIC ASPECTS OF EOSINOPHILIC ESOPHAGITIS ARE MAINTAINED, OR CONTINUE TO IMPROVE, WITH LONG-TERM DUPILUMAB TREATMENT, REGARDLESS OF PRIOR ESOPHAGEAL DILATION. Gastroenterology. 166(5). S–413. 1 indexed citations

Rothenberg, Marc E., Evan S. Dellon, Albert J. Bredenoord, et al.. (2024). A213 DUPILUMAB EFFICACY IN EOSINOPHILIC ESOPHAGITIS PERSISTS FOR HISTOLOGIC, SYMPTOMATIC, AND ENDOSCOPIC OUTCOMES REGARDLESS OF CONCOMITANT HIGH-DOSE PROTON PUMP INHIBITOR USE. Journal of the Canadian Association of Gastroenterology. 7(Supplement_1). 168–169. 1 indexed citations

Murrell, Dédée F., P. Joly, Victoria P. Werth, et al.. (2024). Study Design of a Phase 2/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT. Advances in Therapy. 41(7). 2991–3002. 15 indexed citations

Chehade, Mirna, Evan S. Dellon, Jonathan M. Spergel, et al.. (2023). 605 DUPILUMAB IMPROVES HISTOLOGIC AND ENDOSCOPIC ASPECTS OF EOSINOPHILIC ESOPHAGITIS IN CHILDREN AGED 1-11 YEARS IN THE PHASE 3 EOE KIDS TRIAL. Gastroenterology. 164(6). S–112. 1 indexed citations

Bredenoord, Albert J., Evan S. Dellon, Ikuo Hirano, et al.. (2023). 467 DUPILUMAB IMPROVES HISTOLOGIC, SYMPTOMATIC, AND ENDOSCOPIC ASPECTS OF EOSINOPHILIC ESOPHAGITIS, REGARDLESS OF PRIOR HISTORY OF ESOPHAGEAL DILATION. Gastroenterology. 164(6). S–90. 1 indexed citations

Rothenberg, Marc E., Evan S. Dellon, Margaret H. Collins, et al.. (2023). Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. The Lancet. Gastroenterology & hepatology. 8(11). 990–1004. 53 indexed citations

Blauvelt, Andrew, Andreas Wollenberg, Lawrence F. Eichenfield, et al.. (2022). No Increased Risk of Overall Infection in Adults with Moderate-to-Severe Atopic Dermatitis Treated for up to 4 Years with Dupilumab. Advances in Therapy. 40(1). 367–380. 14 indexed citations

10.

Shabbir, Arsalan, Audrey Cox, Luis Rodriguez-Menocal, Marcela Salgado, & Evangelos V. Badiavas. (2015). Mesenchymal Stem Cell Exosomes Induce Proliferation and Migration of Normal and Chronic Wound Fibroblasts, and Enhance Angiogenesis In Vitro. Stem Cells and Development. 24(14). 1635–1647. 550 indexed citations breakdown →

11.

Rodriguez-Menocal, Luis, Marcela Salgado, Jill Waibel, et al.. (2014). Percutaneous Bone Marrow Transplantation Using Fractional Ablative Erbium:YAG Laser. PLoS ONE. 9(3). e93004–e93004. 14 indexed citations

12.

Shabbir, Arsalan, et al.. (2012). Branchio‐oculo‐facial Syndrome Presenting with Concomitant Thyroglossal Duct Cyst. Pediatric Dermatology. 29(3). 383–384. 3 indexed citations

13.

Shabbir, Arsalan, et al.. (2011). Squamous Cell Carcinoma Developing from an Epidermoid Cyst of the Ear. Dermatologic Surgery. 37(5). 700–703. 10 indexed citations

14.

Zisa, David, Arsalan Shabbir, Michalis Mastri, Gen Suzuki, & Techung Lee. (2009). Intramuscular VEGF repairs the failing heart: role of host-derived growth factors and mobilization of progenitor cells. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 297(5). R1503–R1515. 45 indexed citations

15.

Shabbir, Arsalan, David Zisa, Gen Suzuki, & Techung Lee. (2009). Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen. American Journal of Physiology-Heart and Circulatory Physiology. 296(6). H1888–H1897. 176 indexed citations

16.

Zisa, David, Arsalan Shabbir, Gen Suzuki, & Techung Lee. (2009). Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repair. Biochemical and Biophysical Research Communications. 390(3). 834–838. 96 indexed citations

17.

Lin, Huey, et al.. (2008). Adenoviral expression of vascular endothelial growth factor splice variants differentially regulate bone marrow‐derived mesenchymal stem cells. Journal of Cellular Physiology. 216(2). 458–468. 50 indexed citations

18.

Zisa, David, et al.. (2008). Myocardial oxidative stress, osteogenic phenotype, and energy metabolism are differentially involved in the initiation and early progression of δ-sarcoglycan-null cardiomyopathy. Molecular and Cellular Biochemistry. 321(1-2). 45–52. 19 indexed citations

19.

Lin, Huey, et al.. (2007). Stem cell regulatory function mediated by expression of a novel mouse Oct4 pseudogene. Biochemical and Biophysical Research Communications. 355(1). 111–116. 40 indexed citations

20.

Lee, Paul C., Arsalan Shabbir, Christopher Cardozo, & Avrom J. Caplan. (2004). Sti1 and Cdc37 Can Stabilize Hsp90 in Chaperone Complexes with a Protein Kinase. Molecular Biology of the Cell. 15(4). 1785–1792. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact